Focalis Bio is a biotech company developing cutting-edge gene therapies targeting focal refractory epilepsy (FRE) with the goal of making patients seizure-free
Focalis Bio is a biotech company developing cutting-edge gene therapies targeting focal refractory epilepsy (FRE) with the goal of making patients seizure-free.